BRUSSELS, Nov. 5, 2024 /PRNewswire/ --
European Union key facts:
- With only eight significant merger investigations concluded thus far in 2024, the EC continues to fall behind the average for the first nine months of the year.
- Phase I remedy cases are slowly becoming a thing of the past, representing only one percent of all Phase I cases.
- The proportion of deals abandoned is rising in the EU, reaching 25 percent of total significant merger investigations for the first time since 2011.
- The average duration of both Phase I with remedies and Phase II cases remains high, despite signs of improvement for Phase II cases.
- The rejection of the EC's approach to Article 22 by the ECJ heralds a new era of uncertainty for merging parties, with the EC counting on Member States using their call-in powers to enable referrals.
Read the full report here.
About Dechert
Dechert is a global law firm that advises asset managers, financial institutions and corporations on issues critical to managing their business and their capital - from high-stakes litigation to complex transactions and regulatory matters. We answer questions that seem unsolvable, develop deal structures that are new to the market and protect clients' rights in extreme situations. Our nearly 1,000 lawyers across 20 offices globally focus on the financial services, private equity, private credit, real estate, life sciences and technology sectors.
View original content:https://www.prnewswire.co.uk/news-releases/dechert-antitrust-merger-investigation-timing-tracker-damitt-q3-report-published-302296747.html
